Dr. Reddy’s Laboratories has entered into a definitive agreement with The Dow Chemical Company to acquire a portion of the Dowpharma Small Molecules business associated with sites in Mirfield and Cambridge, UK. The acquisition will include the relevant business, customer contracts, associated products, process technology, intellectual property, trademarks as well as the transfer of the facilities at Mirfield and Cambridge. The two sites and the business employ around 80 people. Dr. Reddy’s w...